Abstract
Human opportunistic yeast infections have become more common in recent years. Many infections are difficult to treat and diagnose due to the large number and diversity of organisms that can cause sickness. In addition, infectious strains eventually develop resistance to one or more antifungal medicines, severely limiting treatment choices and emphasizing the need of early detection of the infective agent and its drug sensitivity profile. Current techniques for detecting species and resistances are insensitive and specific, and they frequently need pre-cultivation of the causal agent, which delays diagnosis. New high-throughput technologies, such as next-generation sequencing or proteomics, make it possible to identify yeast infections more sensitively, accurately, and quickly. Opportunistic yeast pathogens, cause a wide spectrum of superficial and systemic infections, many of which are lethal. In this work, we give an overview of current and newly created approaches. It may be used to determine the presence of yeast infections as well as their medication resistance. Throughout the book, we highlight the following points: Explaining the benefits and drawbacks of each strategy, as well as the most promising advancements on their route to success.